Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP468806.RA-TpQeNyZ7sMf-doVHRv5oZf4vUG32U5lrnKzvFe6h9Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP468806.RA-TpQeNyZ7sMf-doVHRv5oZf4vUG32U5lrnKzvFe6h9Y130_assertion type Assertion NP468806.RA-TpQeNyZ7sMf-doVHRv5oZf4vUG32U5lrnKzvFe6h9Y130_head.
- NP468806.RA-TpQeNyZ7sMf-doVHRv5oZf4vUG32U5lrnKzvFe6h9Y130_assertion wasGeneratedBy ECO_0000203 NP468806.RA-TpQeNyZ7sMf-doVHRv5oZf4vUG32U5lrnKzvFe6h9Y130_provenance.
- NP468806.RA-TpQeNyZ7sMf-doVHRv5oZf4vUG32U5lrnKzvFe6h9Y130_assertion wasDerivedFrom befree-20150227 NP468806.RA-TpQeNyZ7sMf-doVHRv5oZf4vUG32U5lrnKzvFe6h9Y130_provenance.
- NP468806.RA-TpQeNyZ7sMf-doVHRv5oZf4vUG32U5lrnKzvFe6h9Y130_assertion SIO_000772 22012255 NP468806.RA-TpQeNyZ7sMf-doVHRv5oZf4vUG32U5lrnKzvFe6h9Y130_provenance.
- NP468806.RA-TpQeNyZ7sMf-doVHRv5oZf4vUG32U5lrnKzvFe6h9Y130_assertion evidence source_evidence_literature NP468806.RA-TpQeNyZ7sMf-doVHRv5oZf4vUG32U5lrnKzvFe6h9Y130_provenance.
- NP468806.RA-TpQeNyZ7sMf-doVHRv5oZf4vUG32U5lrnKzvFe6h9Y130_assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP468806.RA-TpQeNyZ7sMf-doVHRv5oZf4vUG32U5lrnKzvFe6h9Y130_provenance.